姓名：屈帅

性别：男

学历：博士研究生

职称：副教授

工作单位：福州大学生物科学与工程学院

教育情况：

2018.09-2024.07：北京大学，生物医学工程专业，博士研究生

2014.09-2018.07：哈尔滨工业大学，生物工程专业，本科

工作经历：

2024.08-至今：福州大学，生物科学与工程学院，副教授

所主持的项目及其进展：

福州大学引进人才启动基金（30万元）2025-2027年

主要研究方向：

基因治疗；脂质纳米颗粒（LNP）；超声介导的药物递送

代表性著作：

[1] Qu, S#., Liu, R#., Zhang, N., Xu, Y., Yue, X., & Dai, Z. (2022). Non-viral nucleic acid therapeutics: Revolutionizing the landscape of atherosclerotic treatment. Nano Today, 45, 101514.

[2] Liu, R#., Qu, S#., Xu, Y., Jo, H., & Dai, Z. (2022). Spatial control of robust transgene expression in mouse artery endothelium under ultrasound guidance. Signal Transduction and Targeted Therapy, 7(1), 225.

[3] Qu, S., Liu, R., & Dai, Z. (2022). Imaging-guided gene delivery: seeing is delivering. Journal of Bio-X Research, 5(04), 143-144.

[4] Xin, Z., Qu, S., Qu, Y., Xu, Y., Liu, R., Sun, D., & Dai, Z. (2024). Emerging IL-12-based nanomedicine for cancer therapy. Nano Today, 57, 102331.

[5] Liu, R#., Yang, H#., Qu, S., Yang, P., Zhi, X., Xu, Y., Dai, Z., Qian, L (2023). Photodynamic eradication of intratumoral microbiota with bacteria-targeted micelles overcomes gemcitabine resistance of pancreatic cancer. Aggregate, 00, e423.

[6] Xu, Y., Liu, R., Yang, H., Qu, S., Qian, L., & Dai, Z. (2022). Enhancing Photodynamic Therapy Efficacy Against Cancer Metastasis by Ultrasound-Mediated Oxygen Microbubble Destruction to Boost Tumor-Targeted Delivery of Oxygen and Renal-Clearable Photosensitizer Micelles. ACS Applied Materials & Interfaces.

[7] Liu, R., Xu, Y., Zhang, N., Qu, S., Zeng, W., Li, R., & Dai, Z. (2022). Nanotechnology for Enhancing Medical Imaging. In: Gu, N. (eds) Nanomedicine. Micro/Nano Technologies. Springer, Singapore.

[8] Liu, W., Han, F., Qu, S., Yao, Y., Zhao, J., Akhtar, M. L., ... & Li, Y. (2018). MARVELD1 depletion leads to dysfunction of motor and cognition via regulating glia-dependent neuronal migration during brain development. Cell death & disease, 9(10), 1-17.

[9] Li, K#., Qu, S#., Chen, X., Wu, Q., & Shi, M. (2017). Promising targets for cancer immunotherapy: TLRs, RLRs, and STING-mediated innate immune pathways. International journal of molecular sciences, 18(2), 404.